Subscribe to Newsletter

Refine results:

Refine results

Product Profiles

Results 81–90 of 235

VALSYNTHESE –  celebrating 125 year anniversary of the SSE Group

| Contributed by Valsynthese

Valsynthese, part of SSE Group, is active in the fields of custom synthesis and contract manufacturing for the chemical and pharmaceutical industries.

Providing Solutions for Pediatric Oral Dosage Form Development

| Contributed by Cambrex

Infants, children and adolescents require different dosage forms depending on their swallowing abilities, taste preferences and dosage requirements.

Convert Your Existing Benchtop Glass Bioreactor to Single-Use in Seconds!

| Contributed by Distek

The BIOne is a benchtop scale single-use bioreactor system for mammalian cell growth and recombinant protein production.

Distek BIOne 1250 Bioprocess Control Station - The New Interface of Bioreactors!

| Contributed by Distek

Distek has revolutionized benchtop scale bioreactors with the release of our BIOne 1250 bioprocess control station.

Leading the way for the next-generation capsule

| Contributed by Qualicaps

Qualicaps® is responsible for several milestones in the history of hard capsule development within the pharmaceutical industry.

The Customer in the spot light

| Contributed by Valsynthese

A team of scientists, engineers and technicians fully at your disposal, equipped with state of the art laboratories and several production sites.

Oral Dose Development

| Contributed by Catalent

Leveraging its global early-phase development centers of excellence, Catalent offers its partners end-to-end solutions for oral development.

Extending the Lower Limits of Quantification of Therapeutic Oligonucleotide Through Microflow LC-MS/MS

| Contributed by Sciex

Therapeutic Oligonucleotide quantification has been challenging. But what happens when you move from regular flow to Microflow?

Highly Potent API Development & Manufacturing Services

| Contributed by Cambrex

Cambrex offers clients a truly end-to-end partnership for the research, development and manufacture of small molecule highly potent APIs (HPAPIs).

IPS Showcases INNOPHEX and Pharma 4.0 at Annual Technologies Tours at INTERPHEX

| Contributed by IPS

IPS, in collaboration with INTERPHEX and the newly launched INNOPHEX, curated six unique IPS Technologies Tours with a focus on Pharma 4.0.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register